Selective Activation of the Glucocorticoid Receptor by Steroid Antagonists in Human Breast Cancer and Osteosarcoma Cells
Open Access
- 1 June 2000
- journal article
- Published by Elsevier
- Vol. 275 (23), 17771-17777
- https://doi.org/10.1074/jbc.m908729199
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Structure and specificity of nuclear receptor–coactivator interactionsGenes & Development, 1998
- Different positioning of the ligand-binding domain helix 12and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonistsThe EMBO Journal, 1998
- Second Cancers After Adjuvant Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivoThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Novel mechanisms of antiprogestin actionThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerizationThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- The interaction of transcription factors with nucleosomal DNABioEssays, 1992
- Novel antiprogestins Org 31806 and 31710: Interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexesThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Transcription Factor Loading on the MMTV Promoter: A Bimodal Mechanism for Promoter ActivationScience, 1992
- New steroids with antiprogestational and antiglucocorticoid activitiesSteroids, 1984